期刊文献+

成人原发性噬血细胞综合征一例报告及文献复习 被引量:15

A case report of adult onset of primary hemophagocytic syndrome with literature review
原文传递
导出
摘要 目的探讨成人原发性噬血细胞综合征(HPS)的诊断要点、成人患者基因表型特点与疾病发生的关系。方法对1例根据HLH-2004诊断标准确诊的成人HPS患者临床特点进行分析,并采用聚合酶链反应检测穿孔素基因(PRF1)、STX11、UNC13D、SH2D1A和RAB27A基因序列并探讨其发病机制。结果确诊病例为48岁男性患者,表现为反复发热、全血细胞减少伴淋巴结肿大,骨髓中存在噬血现象、血清铁蛋白升高(2000μg/L)、NK细胞活性下降(20.13%)、可溶性CD25升高(1227.7万U/L),根据HLH-2004诊断标准确诊为HPS。患者存在病毒感染,未找到其他可能引起HPS的疾病,予抗病毒治疗效果不佳。最终经基因测序证实为PRFl基因突变的原发性HPS。结论原发性HPS虽多见于婴幼儿,但青少年及成年仍有发病可能,对病情反复发作、原发病不明的患者进行基因筛查十分必要。分子遗传学改变是鉴别原发性和获得性HPS的关键。 Objective To introduce the clinical manifestations and laboratory tests of adult onset of primary hemophagocytic syndrome ( HPS), and to investigate the essentials of diagnosis and the genotype characteristics in adult onset patient. Methods The definite diagnosis of HPS was made according to HLH- 2004. Exons of PRF1, STXll, UNC13D, SH2D1A and RAB27A genes coding region were amplified using polymerase chain reaction. Results A 48-year-old man was admitted to our hospital because of recurrent fe- ver, pancytopenia and lymph node enlargement. His laboratory test revealed bone marrow hemophagocytosis, elevated ferritin level (2000 μg/L) , reduced level of NK cell activity (20.13%) and elevated soluble CD25 level ( 12277 U/ml). Based on the HLH-2004 diagnostic criteria, the patient was diagnosed as HPS. The patient had viral infection, and no other primary disease was identified that would cause HPS. The patient re- sponded poorly to anti-viral therapy. DNA sequencing was used to confirm that perforin gene mutations might be one of the causes of the patient suffered from primary HPS. Conclusions Although primary HPS usually affects infants and young children, it also occurred in teens and adults. It is essential to perform genetic screenings to patient whose illnesses recur with unknown causes. In addition, detection of molecular genetic alterations can be used to distinguish primary HPS from acquired HPS.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第4期291-293,共3页 Chinese Journal of Hematology
基金 北京市科技计划(D101100050010005) 首都医学发展科研基金(2009.1032) 北京友谊医院科研启动基金(YYQD-KT2011-6)
关键词 淋巴组织细胞增多症 嗜血细胞性 成年人 穿孔素 Lymphohistioeytosis,hemophagocytic Adult Perforin
  • 相关文献

参考文献14

  • 1Zur Stadt U,Beutel K,Kolberg S. Mutation spectrum in children with primary hemophagocytic lymphohistioeytosis:molecular and functional analyses of PRF-1,UNC13D,STX11,and RAB27A[J].Human Mutation,2006.62-68.
  • 2Henter JI,Home AC,Arico M. HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lymphohistioeytosis[J].Pe-diatr Blood Cancer,2007.124-131.
  • 3Janka GE. Familial and acquired hemophagocytic lymphohistioeytosis[J].European Journal of Pediatrics,2007.95-109.
  • 4Clementi R,Emmi L,Maccario R. Adult onset and atypical presentation of hemophagocytic lymphohistioeytosis in siblings carrying PRF1 mutations[J].Blood,2002.2266-2267.
  • 5Mancebo E,Allende LM,Guzman M. Familial hemophagocytic lymphohistioeytosis in an adult patient homozygous for A91V in the perform gene,with tuberculosis infection[J].Haematologica,2006.1257-1260.
  • 6Nagafuji K,Nonami A,Kumano T. Perform gene mutations in adult-onset hemophagocytic lymphohistioeytosis[J].Haematologica,2007.978-981.
  • 7Janka GE,Schneider EM. Modern management of children with haemophagocytic lymphohistioeytosis[J].British Journal of Haematology,2004.4-14.
  • 8Farquhar JW,Claireaux AE. Familial haemophagocytic reticulo-sis[J].Archives of Disease in Childhood,1952.519-525.doi:10.1136/adc.27.136.519.
  • 9Cetica V,Pende D,Griffiths GM. Molecular basis of familial hemophagocytic lymphohistioeytosis[J].Haematologica,2010.538-541.
  • 10陈华,王昭,王旖旎,王晶,石吴林.原发性噬血细胞综合征一例报告附文献复习[J].中华血液学杂志,2010,31(11):779-780. 被引量:7

共引文献6

同被引文献133

  • 1丁秋琳,郭霞,李强.迟发性家族性噬血细胞综合征及严重中枢神经系统病变患儿的PRF1基因变异分析[J].中华医学遗传学杂志,2019,36(6):592-594. 被引量:3
  • 2王艳荣,邹典定,周东风.儿童嗜血细胞综合征10例临床分析[J].医学新知,2006,16(1):51-52. 被引量:6
  • 3Verbsky JW, Grossman WJ. Hemophagocytic lymphohis- tiocytosis: diagnosis, pathophysiology, treatment, and fu- ture perspectives [J]. Ann Med, 2006, 38(1): 20-31.
  • 4Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis [J]. Semin Oncol, 1991, 18(1): 29-33.
  • 5Henter JI, Home A, Aric6 M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2007, 48 (2): 124-131.
  • 6Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders [J]. Hematology Am Soc Hematol Educ Program, 2009: 127-131.
  • 7Johnson TS, Villanueva J, Filipovich AH, et al. Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders [J]. J Immunol Methods, 2011, 364(1-2): 1-13.
  • 8Harada H, Saijo K, Ishiwata I, et al. A GFP-transfected HFWT cell line, GHINK-1, as a novel target for non-RI activated natural killer cytotoxicity assay [J]. Hum Cell, 2004, 17(1): 43-48.
  • 9Chung HI, Park C J, Lim JH, et al. Establishment of a reference interval for natural killer cell activity through flow cytometry and its clinical application in the diagnosis of hemophagocytic lymphohistiocytosis [J]. Int J Lab Hematol, 2010, 32(2): 239-247.
  • 10Marcenaro S, Gallo F, Martini S, et al. Analysis of naturalkiller-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Muncl3-4 defect and discriminates between genetic subtypes of the disease [J]. Blood, 2006, 108(7): 2316-2323.

引证文献15

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部